208 related articles for article (PubMed ID: 31461552)
21. Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR.
Liang YY; Huang JC; Tang RX; Chen WJ; Chen P; Cen WL; Shi K; Gao L; Gao X; Liu AG; Peng XT; Chen G; Huang SN; Fang YY; Gu YY
World J Surg Oncol; 2018 Feb; 16(1):22. PubMed ID: 29394946
[TBL] [Abstract][Full Text] [Related]
22. Multiple mutations of lung squamous cell carcinoma shared common mechanisms.
Li Q; Hou J; Hu Z; Gu B; Shi Y
Oncotarget; 2016 Nov; 7(48):79629-79636. PubMed ID: 27835590
[TBL] [Abstract][Full Text] [Related]
23. Construction of a competing endogenous RNA network using differentially expressed lncRNAs, miRNAs and mRNAs in non‑small cell lung cancer.
Wang XW; Guo QQ; Wei Y; Ren KM; Zheng FS; Tang J; Zhang HY; Zhao JG
Oncol Rep; 2019 Dec; 42(6):2402-2415. PubMed ID: 31638248
[TBL] [Abstract][Full Text] [Related]
24. Transcription Factors Contribute to Differential Expression in Cellular Pathways in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Liu S; Wang X; Qin W; Genchev GZ; Lu H
Interdiscip Sci; 2018 Dec; 10(4):836-847. PubMed ID: 30039492
[TBL] [Abstract][Full Text] [Related]
25. Considering smoking status, coexpression network analysis of non-small cell lung cancer at different cancer stages, exhibits important genes and pathways.
Mortezaei Z; Tavallaei M; Hosseini SM
J Cell Biochem; 2019 Nov; 120(11):19172-19185. PubMed ID: 31271232
[TBL] [Abstract][Full Text] [Related]
26. Identification of microRNAs involved in pathways which characterize the expression subtypes of NSCLC.
Halvorsen AR; Ragle Aure M; Õjlert ÅK; Brustugun OT; Solberg S; Nebdal D; Helland Å
Mol Oncol; 2019 Dec; 13(12):2604-2615. PubMed ID: 31505091
[TBL] [Abstract][Full Text] [Related]
27. Circulating metabolite profiles to predict overall survival in advanced non-small cell lung cancer patients receiving first-line chemotherapy.
Shen J; Ye Y; Chang DW; Huang M; Heymach JV; Roth JA; Wu X; Zhao H
Lung Cancer; 2017 Dec; 114():70-78. PubMed ID: 29173770
[TBL] [Abstract][Full Text] [Related]
28. Bioinformatics analyses of the differences between lung adenocarcinoma and squamous cell carcinoma using The Cancer Genome Atlas expression data.
Sun F; Yang X; Jin Y; Chen L; Wang L; Shi M; Zhan C; Shi Y; Wang Q
Mol Med Rep; 2017 Jul; 16(1):609-616. PubMed ID: 28560415
[TBL] [Abstract][Full Text] [Related]
29. Effect of miR‑146a‑5p on tumor growth in NSCLC using chick chorioallantoic membrane assay and bioinformatics investigation.
Huang WT; Cen WL; He RQ; Xie Y; Zhang Y; Li P; Gan TQ; Chen G; Hu XH
Mol Med Rep; 2017 Dec; 16(6):8781-8792. PubMed ID: 28990079
[TBL] [Abstract][Full Text] [Related]
30. Differentially expressed and activated proteins associated with non small cell lung cancer tissues.
Nigro E; Imperlini E; Scudiero O; Monaco ML; Polito R; Mazzarella G; Orrù S; Bianco A; Daniele A
Respir Res; 2015 Jun; 16(1):74. PubMed ID: 26104294
[TBL] [Abstract][Full Text] [Related]
31. 24h-gene variation effect of combined bevacizumab/erlotinib in advanced non-squamous non-small cell lung cancer using exon array blood profiling.
Baty F; Joerger M; Früh M; Klingbiel D; Zappa F; Brutsche M
J Transl Med; 2017 Mar; 15(1):66. PubMed ID: 28359318
[TBL] [Abstract][Full Text] [Related]
32. Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in Lung Adenocarcinoma.
Liu X; Chen L; Zhang T
Cancer Control; 2018; 25(1):1073274818778001. PubMed ID: 29843532
[TBL] [Abstract][Full Text] [Related]
33. Microarray data re-annotation reveals specific lncRNAs and their potential functions in non-small cell lung cancer subtypes.
Zhou D; Xie M; He B; Gao Y; Yu Q; He B; Chen Q
Mol Med Rep; 2017 Oct; 16(4):5129-5136. PubMed ID: 28849055
[TBL] [Abstract][Full Text] [Related]
34. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
[TBL] [Abstract][Full Text] [Related]
35. Nuclear TAZ activity distinctly associates with subtypes of non-small cell lung cancer.
Wang Y; Han Y; Guo Z; Yang Y; Ren T
Biochem Biophys Res Commun; 2019 Feb; 509(3):828-832. PubMed ID: 30638934
[TBL] [Abstract][Full Text] [Related]
36. [Nuclear factor-kappaB activity and its correlation with cell proliferation in non-small cell lung cancer tissues].
Zhang J; Xu YJ; Zhang ZX; DU CL; Qiao LF; Ni W; Chen SX
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Oct; 30(10):771-5. PubMed ID: 18218209
[TBL] [Abstract][Full Text] [Related]
37. Role of high expression levels of STK39 in the growth, migration and invasion of non-small cell type lung cancer cells.
Li Z; Zhu W; Xiong L; Yu X; Chen X; Lin Q
Oncotarget; 2016 Sep; 7(38):61366-61377. PubMed ID: 27542260
[TBL] [Abstract][Full Text] [Related]
38. Expression of miRNAs in non-small-cell lung carcinomas and their association with clinicopathological features.
Tafsiri E; Darbouy M; Shadmehr MB; Zagryazhskaya A; Alizadeh J; Karimipoor M
Tumour Biol; 2015 Mar; 36(3):1603-12. PubMed ID: 25384507
[TBL] [Abstract][Full Text] [Related]
39. Co-Expression Analysis Reveals Mechanisms Underlying the Varied Roles of NOTCH1 in NSCLC.
Sinicropi-Yao SL; Amann JM; Lopez DLY; Cerciello F; Coombes KR; Carbone DP
J Thorac Oncol; 2019 Feb; 14(2):223-236. PubMed ID: 30408569
[TBL] [Abstract][Full Text] [Related]
40. AEG-1 mRNA expression in non-small cell lung cancer is associated with increased tumor angiogenesis.
Ma Z; Chen Y; Dong S; Xu X; Liu J; Song P; Yu C; Dai L
Pathol Res Pract; 2017 Oct; 213(10):1257-1263. PubMed ID: 28941723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]